These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3035515)

  • 1. Modulation of dopamine receptors by thyrotropin-releasing hormone in the rat brain.
    Funatsu KS; Inanaga K
    Peptides; 1987; 8(2):319-25. PubMed ID: 3035515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxytryptamine and (+)-lysergic acid diethylamide displace [3H]thyrotropin-releasing hormone at its binding sites in the rat limbic forebrain.
    Teshima S; Funatsu K; Satoh H; Inanaga K
    Regul Pept; 1986 Jul; 14(4):293-9. PubMed ID: 3018845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic receptors in bovine retina and their interaction with thyrotropin-releasing hormone.
    Reading HW
    J Neurochem; 1983 Dec; 41(6):1587-95. PubMed ID: 6417273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel substance P binding site in rat brain regions modulates TRH receptor binding.
    Sharif NA
    Neurochem Res; 1990 Oct; 15(10):1045-9. PubMed ID: 1706485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norvaline2-TRH: binding to TRH receptors in rat brain homogenates.
    Vonhof S; Feuerstein GZ; Cohen LA; Labroo VM
    Eur J Pharmacol; 1990 May; 180(1):1-12. PubMed ID: 2163861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of thyrotropin-releasing hormone on general behavior and striatal [3H]spiperone binding in developing rats.
    Oki K; Kinoshita Y; Nomura Y; Segawa T
    J Pharmacobiodyn; 1983 Sep; 6(9):607-12. PubMed ID: 6418875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraventricular administration of thyrotrophin-releasing hormone (TRH) suppresses prolactin secretion and synthesis: a possible involvement of dopamine release by TRH from rat hypothalamus.
    Ikegami H; Jikihara H; Koike K; Morishige K; Kurachi H; Yamamoto N; Hirota K; Miyake A; Tanizawa O
    J Endocrinol; 1992 Apr; 133(1):59-66. PubMed ID: 1355520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone.
    Bhargava HN; Das S
    Brain Res; 1986 Mar; 368(2):262-7. PubMed ID: 3008927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
    Das S; Bhargava HN
    Neuropharmacology; 1987 Aug; 26(8):1141-6. PubMed ID: 2889163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central and peripheral type benzodiazepine ligands displace [3H][3-ME-HIS2]TRH from its binding sites in the brain and the anterior pituitary and antagonize the effect of TRH in the rat duodenum.
    Järvinen A; Paakkari I; Männistö PT
    Neuropeptides; 1991 Jul; 19(3):147-55. PubMed ID: 1654530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin-releasing hormone (TRH): apparent receptor binding in rat spinal cord.
    Prasad C; Edwards RM
    Brain Res; 1984 Oct; 311(1):1-6. PubMed ID: 6091847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated treatment with amitriptyline or electroconvulsive shock does not affect thyrotropin releasing hormone receptors in discrete rat brain structures.
    Przegalinski E; Jaworska L; Konarska R
    Neurosci Lett; 1990 Jul; 115(1):86-91. PubMed ID: 2170869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of hemorrhagic shock on thyrotropin-releasing hormone and its receptors in discrete regions of rat brain.
    Ono T; Ogawa N; Mori A
    Regul Pept; 1989 May; 25(2):215-22. PubMed ID: 2547227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogs of thyrotropin-releasing hormone (TRH): receptor affinities in brains, spinal cords, and pituitaries of different species.
    Sharif NA; To ZP; Whiting RL
    Neurochem Res; 1991 Feb; 16(2):95-103. PubMed ID: 1652701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of rat striatal thyrotropin-releasing hormone receptors produced by repeated methamphetamine administration.
    Nakashima M; Kajita S; Otsuki S
    Biol Psychiatry; 1989 Jan; 25(2):191-9. PubMed ID: 2539202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of neurotensin, substance P and TRH on the regulation of dopamine receptors in rat brain.
    Simasko SM; Weiland GA
    Eur J Pharmacol; 1984 Nov; 106(3):653-6. PubMed ID: 6083874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro biochemical characterization and autoradiographic distribution of 3H-thyrotropin-releasing hormone binding sites in rat brain sections.
    Rostène WH; Morgat JL; Dussaillant M; Rainbow TC; Sarrieau A; Vial M; Rosselin G
    Neuroendocrinology; 1984 Jul; 39(1):81-6. PubMed ID: 6087185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation of thyrotropin releasing hormone receptors in specific brain regions during the development of hypertension in spontaneously hypertensive rats.
    Bhargava HN; Das S; Bansinath M
    Peptides; 1987; 8(2):231-5. PubMed ID: 3035513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
    Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
    Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic dihydroergotoxine administration sets on receptors for enkephalin and thyrotropin releasing hormone in the aged-rat brain.
    Ogawa N; Mizuno S; Mori A; Kuroda H
    Peptides; 1984; 5(1):53-6. PubMed ID: 6324150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.